K4 Elite
K4 Elite
A synthetic pentadecapeptide derived from a partial sequence of human gastric juice protein, studied in preclinical models for its effects on tendon, ligament, muscle, and gastrointestinal tissue.
BPC-157 is a synthetic pentadecapeptide whose sequence corresponds to a fragment of a protective protein originally isolated from human gastric juice. It has been the subject of a substantial body of preclinical (animal and in vitro) research, primarily conducted by a single group of laboratories in Croatia.
Reported research interest has centered on tissue-repair processes across several organ systems, including the gastrointestinal tract, tendon, ligament, muscle, and vascular tissue. The peptide is frequently described in the literature as "stable in human gastric juice," a property that has motivated study of both parenteral and enteral administration in animal models.
BPC-157 is not an approved drug in any jurisdiction and remains an investigational compound. The available evidence is overwhelmingly preclinical, and controlled human clinical trial data are limited.
Proposed mechanisms in the preclinical literature focus on modulation of angiogenesis and vascular repair. Studies have reported upregulation of vascular endothelial growth factor receptor 2 (VEGFR2) signaling and increased nitric oxide pathway activity, which are hypothesized to support the formation of new blood vessels during tissue healing.
Additional proposed actions described in animal studies include interaction with the nitric oxide (NO) system, effects on growth-factor expression such as early growth response 1 (EGR-1), and modulation of the fibroblast and collagen-organizing processes involved in tendon and ligament repair. These mechanisms are hypotheses derived from animal and cell-culture work and have not been confirmed in controlled human studies.
In a rat Achilles tendon transection study, Krivic and colleagues reported that BPC-157 administration was associated with accelerated functional and biomechanical recovery of the transected tendon compared with controls; outcome measures included tendon load-to-failure and functional walking assessment [1].
Chang and colleagues investigated BPC-157 in cultured tendon fibroblasts and a rat model, reporting increased cell survival, spreading, and migration in vitro and upregulation of the growth hormone receptor as a candidate mechanism for the observed tendon-fibroblast effects [3].
In gastrointestinal injury models, Sikiric and colleagues summarized rodent studies in which BPC-157 was associated with reduced gastric and intestinal lesion severity across a range of experimentally induced injuries, with mucosal integrity as the primary measured outcome [2].
Combinations examined in the research literature. Descriptive only — not a recommendation to combine compounds.